OBJECTIVE: We examined pregnant women's intention to obtain the seasonal influenza vaccine via a randomized controlled study examining the effects of immunization history, message exposure, and sociodemographic correlates. METHODS:Pregnant women ages 18-50 participated in a randomized message framing study from September 2011 through May 2012. Venue-based sampling was used to recruit racial and ethnic minority women throughout Atlanta, Georgia. Key outcomes were evaluated using bivariate and multivariate analyses. RESULTS: History of influenza immunization was positively associated with intent to immunize during pregnancy [OR=2.31, 90%CI: (1.06, 5.00)]. Significant correlates of intention to immunize included perceived susceptibility to influenza during pregnancy [OR=3.8, 90% CI: (1.75, 8.36)] and vaccine efficacy [OR=10.53, 90% CI: (4.34, 25.50)]. Single message exposure did not influence a woman's intent to vaccinate. CONCLUSIONS: Prior immunization, perceived flu susceptibility and perceived vaccine effectiveness promoted immunization intent among this population of pregnant minority women. Vaccine efficacy and disease susceptibility are critical to promoting immunization among women with no history of seasonal influenza immunization, while those who received the vaccine are likely to do so again. These findings provide evidence for the promotion of repeated exposure to vaccine messages emphasizing vaccine efficacy, normative support, and susceptibility to influenza.
RCT Entities:
OBJECTIVE: We examined pregnant women's intention to obtain the seasonal influenza vaccine via a randomized controlled study examining the effects of immunization history, message exposure, and sociodemographic correlates. METHODS: Pregnant women ages 18-50 participated in a randomized message framing study from September 2011 through May 2012. Venue-based sampling was used to recruit racial and ethnic minority women throughout Atlanta, Georgia. Key outcomes were evaluated using bivariate and multivariate analyses. RESULTS: History of influenza immunization was positively associated with intent to immunize during pregnancy [OR=2.31, 90%CI: (1.06, 5.00)]. Significant correlates of intention to immunize included perceived susceptibility to influenza during pregnancy [OR=3.8, 90% CI: (1.75, 8.36)] and vaccine efficacy [OR=10.53, 90% CI: (4.34, 25.50)]. Single message exposure did not influence a woman's intent to vaccinate. CONCLUSIONS: Prior immunization, perceived flu susceptibility and perceived vaccine effectiveness promoted immunization intent among this population of pregnant minority women. Vaccine efficacy and disease susceptibility are critical to promoting immunization among women with no history of seasonal influenza immunization, while those who received the vaccine are likely to do so again. These findings provide evidence for the promotion of repeated exposure to vaccine messages emphasizing vaccine efficacy, normative support, and susceptibility to influenza.
Authors: Leslie B Snyder; Mark A Hamilton; Elizabeth W Mitchell; James Kiwanuka-Tondo; Fran Fleming-Milici; Dwayne Proctor Journal: J Health Commun Date: 2004
Authors: Indu B Ahluwalia; Denise J Jamieson; Sonja A Rasmussen; Denise D'Angelo; David Goodman; Hanna Kim Journal: Obstet Gynecol Date: 2010-10 Impact factor: 7.661
Authors: Jonathan Van 't Riet; Anthony D Cox; Dena Cox; Gregory D Zimet; Gert-Jan De Bruijn; Bas Van den Putte; Hein De Vries; Marieke Q Werrij; Robert A C Ruiter Journal: Psychol Health Date: 2014-03-27
Authors: Steven B Black; Henry R Shinefield; Eric K France; Bruce H Fireman; Sharon T Platt; David Shay Journal: Am J Perinatol Date: 2004-08 Impact factor: 1.862
Authors: Paula M Frew; Laura A Randall; Fauzia Malik; Rupali J Limaye; Andrew Wilson; Sean T O'Leary; Daniel Salmon; Meghan Donnelly; Kevin Ault; Matthew Z Dudley; Vincent L Fenimore; Saad B Omer Journal: Hum Vaccin Immunother Date: 2018-02-15 Impact factor: 3.452
Authors: Paula M Frew; Jennifer L Kriss; Allison T Chamberlain; Fauzia Malik; Yunmi Chung; Marielysse Cortés; Saad B Omer Journal: Hum Vaccin Immunother Date: 2016-08-02 Impact factor: 3.452
Authors: Mallory K Ellingson; Matthew Z Dudley; Rupali J Limaye; Daniel A Salmon; Sean T O'Leary; Saad B Omer Journal: Expert Rev Vaccines Date: 2019-01-28 Impact factor: 5.217
Authors: Allison T Chamberlain; Katherine Seib; Kevin A Ault; Eli S Rosenberg; Paula M Frew; Marielysse Cortes; Ellen A S Whitney; Ruth L Berkelman; Walter A Orenstein; Saad B Omer Journal: Hum Vaccin Immunother Date: 2016-04-15 Impact factor: 3.452
Authors: Jennifer P King; Kayla E Hanson; James G Donahue; Jason M Glanz; Nicola P Klein; Allison L Naleway; Frank DeStefano; Eric Weintraub; Edward A Belongia Journal: Vaccine Date: 2020-01-25 Impact factor: 3.641
Authors: Matthew Z Dudley; Rupali J Limaye; Daniel A Salmon; Saad B Omer; Sean T O'Leary; Mallory K Ellingson; Christine I Spina; Sarah E Brewer; Robert A Bednarczyk; Fauzia Malik; Paula M Frew; Allison T Chamberlain Journal: Public Health Rep Date: 2021-01-28 Impact factor: 2.792
Authors: Robert A Bednarczyk; Paula M Frew; Daniel A Salmon; Ellen Whitney; Saad B Omer Journal: Hum Vaccin Immunother Date: 2017-01-06 Impact factor: 3.452